Alkem Laboratories · NSE: ALKEM · BSE: 539523
Q1 FY19 results · Apr–Jun 2018
Alkem Laboratories reported revenue from operations of ₹1,669.46 crore and net profit of ₹137.27 crore for Q1 FY19 (Apr–Jun 2018), on a consolidated basis.
| Item | Q1 FY19 | Q1 FY18 | YoY | Q4 FY18 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,669.46 | — | — | — | — |
| Other income | 16.25 | — | — | — | — |
| Total income | 1,685.71 | — | — | — | — |
| Profit before tax | 171.77 | — | — | — | — |
| Net profit for the period | 137.27 | — | — | — | — |
| Attributable to shareholders of the company | 136.15 | — | — | — | — |
| EPS, basic (₹) | 11.39 | — | — | — | — |
| Net margin (%) | 8.2 | — | — |
| Item | Q1 FY19 | Q1 FY18 | YoY | Q4 FY18 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,280.36 | — | — | — | — |
| Other income | 8.97 | — | — | — | — |
| Total income | 1,289.33 | — | — | — | — |
| Profit before tax | 157.62 | — | — | — | — |
| Net profit for the period | 129.49 | — | — | — | — |
| EPS, basic (₹) | 10.83 | — | — | — | — |
| Net margin (%) | 10.1 | — | — |
Consolidated
- Filed with BSE
- 10 Aug 2018, 16:19 IST
- Board meeting
- 10 Aug 2018
- Period
- 01 Apr 2018 to 30 Jun 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 10 Aug 2018, 16:19 IST
- Board meeting
- 10 Aug 2018
- Period
- 01 Apr 2018 to 30 Jun 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE